Earlier this month, Euroz Hartleys released an Analyst Report on Argenica Therapeutics.The initial investment case within the report suggests that "the prize, should ARG-007 be clinically successful, is huge"Read the full report here: https://bit.ly/36ThM4q
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
0.010(1.33%) |
Mkt cap ! $97.35M | |||
| Open | High | Low | Value | Volume |
| 76.0¢ | 77.5¢ | 75.0¢ | $154.6K | 203.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7573 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 76.5¢ | 1327 | 1 |
View Market Depth
| Last trade - 14.55pm 11/11/2024 (20 minute delay) ? |
| AGN (ASX) Chart |